McKinsey July 21, 2025
Gautam Kumra

Dilip Shanghvi, chairman and managing director of Sun Pharma, discusses how India’s top pharmaceutical company has grown, adapted, and innovated to become the multinational corporation it is today.

Dilip Shanghvi established Sun Pharma more than 40 years ago, and since its founding, the Mumbai-based company has become the largest pharmaceutical company in India and is active in more than 100 countries across the globe. After four decades, Shanghvi has succeeded in developing the company by approaching bold risks in a calculated way, balancing resilience and innovation. But he hasn’t done it alone—Shanghvi has also prioritized building a collaborative and loyal team with a similar mission-driven mindset that allows the company to continuously grow and reach new markets.

McKinsey’s Asia Chairman...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: Biotechnology, Interview / Q&A, Pharma, Pharma / Biotech, Trends
What’s new with GLP-1s
Navigating the Shift: 2026 Medicare Drug Pricing and the Future of Pharmacy
Podcast: Medicaid vs. 340B: A Drug Pricing Clash (Sayeh Nikpay)
283: A candid conversation: Physicians on the front lines of GLP‑1 care
BigHat, Revvity Collaborate with Eli Lilly, Immunai Signs Agreement with Bristol Myers Squibb, SandboxAQ Launches New AI Model

Share Article